Posterior Capsulotomy Rate And Dysphotopsias Following Implantation Of Hoya iSert 250 Monofocal Intraocular Lens: 24 Month Study


  •   Ejaz Ansari


Purpose: to evaluate dysphotopsias, patient satisfaction and posterior capsulotomy rate in patients undergoing phacoemulsification and implantation with Hoya iSert 250 monofocal intraocular lens (IOL).

Design: retrospective cohort study. Setting- Teaching unit at a District General Hospital, UK.

Methods: patients were implanted with the hydrophobic acrylic Hoya iSert 250 monofocal IOL through a 2.2mm clear corneal/ limbal incision. For dysphotopsia data, patients responded to a telephone questionnaire describing any visual symptoms and their satisfaction. Nd:YAG laser capsulotomy data were collected retrospectively from electronic medical records, paper notes and laser records. Eyes from patients (mean age 73.6 range 64-93 years) undergoing cataract surgery with implantation of Hoya iSert 250 IOL during the period January 1, 2014 and July 31, 2014, and 2-year follow-up were analysed.

Main outcome measures: dysphotopsia rate, patient satisfaction and posterior capsulotomy rate.

Results: 106 patients had the Hoya iSert 250 lenses implanted over a seven month period in 2014. 88 patients were contacted at 24 months post- operatively. 18 had passed away or were not contactable. 61 patients completed the survey. 15 patients (24.5%) reported transient positive dysphotopsias. One patient (1.6%) reported negative dysphotopsia. 95% were either very satisfied or satisfied with their vision (59% 'very satisfied' and 36% 'satisfied'). 3 patients (4.9%) had a YAG laser capsulotomy within 24 months post-operatively.

Conclusions: the Hoya iSert 250 monofocal IOL was associated with low dysphotopsia and posterior capsulotomy rates with the majority of patients being 'Very Satisfied' with their vision at 24 months. Posterior capsulotomy rate and dysphotopsias following implantation of Hoya iSert 250 monofocal intraocular lens: 24 month study.


Keywords: Capsulotomy; Nd:YAG; dysphotopsia; hydrophilic; hydrophobic


Lundstrom M, Stenevi U, Thorburn W. The Swedish National Cataract Register: a 9-year review. Acta Ophthalmol Scand 2002; 80:248–257.

Lundstrom M, Barry P, Leite H, Seward U, Stenevi U. 1998 European Cataract Outcome Study; report from the European Cataract Outcome Study Group. J Cataract Refract Surg 2001; 27:1176–1184.

Hahn U, Krummenauer F, Kolbl B, Neuhann T, Schayan- Araghi K, Schmickler S, von Wolff K, Weindler J, Will T, Neuhann I. Determination of valid benchmarks for outcome indicators in cataract surgery; a multicenter, prospective cohort trial. Ophthalmology 2011; 118:2105–2112.

Raj SM, Vasavada AR, Johar SR, Vasavada VA, Vasavada VA. Post-operative capsular opacification: a review. Int J Biomed Sci. 2007; 3:237–50.

NICE. Cataracts in adults: management. Full guideline. United Kingdom: NICE; 2017.

American Academy of Ophthalmology. Nd:YAG laser posterior capsulotomy. ndyag-laser-posterior-capsulotomy-3.

Perez-Vives C. Biomaterial influence on intraocular lens performance: an overview. J Ophthalmol. 2018;2018: 2687385.

Kossack N, Schindler C, Weinhold I, Hickstein L, Lehne M, Walker J, et al. German claims data analysis to assess impact of different intraocular lenses on posterior capsule opacification and related healthcare costs. J Public Health. 2018;26: 81–90.

The Way Forward- Cataract.

Auffarth GU, Brezin A, Caporossi A, Lafuma A, Mendicute J, Berdeaux G. Comparison of Nd:YAG capsulotomy rates following phacoemulsification with implantation of PMMA, silicone, or acrylic intra-ocular lenses in four European countries. Ophthalmic Epidemiol. 2004; 11:319–29.

Ernest PH. Posterior capsule opacification and neodymium: YAG capsulotomy rates with AcrySof acrylic and PhacoFlex II silicone intraocular lenses. J Cataract Refract Surg. 2003; 29:1546–50.

Chang A, Kugelberg M. Posterior capsule opacification 9 years after phacoemulsification with a hydrophobic and a hydrophilic intraocular lens. Eur J Ophthalmol. 2017;27: 164–8.

Mamalis N (2000) Complications of foldable intraocular lenses requiring explantation or secondary intervention- 1998 survey. J Cataract Refract Surg 26: 810-816.

Kinnard K, Jarstad A, Olson RJ (2013) Correlation of visual quality with satisfaction and function in a normal cohort of pseudophakic patients. J Cataract Refract Surg 39: 590-597.

Vyas, J. Incidence of Dysphotopsia in Patients Implanted with the C-flex® Intraocular Lens with 360° Enhanced Edge: A Questionnaire-Based Study. Clin Exp Ophthalmol 2015, 6:1

Tester R, Pace NL, Samore M, Olson RJ (2000) Dysphotopsia in phakic and pseudophakic patients: incidence and relation to intraocular lens type. J Cataract Refract Surg 26: 810-816.

Wallin TR, Hinckley M, Nilson C, Olson RJ. A clinical comparison of single piece and three-piece truncated hydrophobic acrylic intraocular lenses. Am J Ophthalmol 2003; 136: 614-619.

Mester U, Heinen S, Kaymak H. Clinical results of the aspheric intraocular lens FY-60AD (Hoya) with particular respect to decentration and tilt. Ophthalmologe. 2010 Sep;107(9):831-6. [Article in German].

Bournas P, Drazinos S, Kanellas D, Arvanitis M, Vaikoussis E. Dysphotopsia after cataract surgery: comparison of four different intraocular lenses. Ophthalmologica. 2007;221(6):378-83.

Radford SW, Carlsson AM, Barrett GD. Comparison of pseudophakic dysphotopsia with Akreos Adapt and SN60-AT intraocular lenses. J Cataract Refract Surg. 2007 Jan;33(1):88-93.

Shambhu S, Shanmuganathan VA, Charles SJ. The effect of lens design on dysphotopsia in different acrylic IOLs. Eye (Lond). 2005 May;19(5):567-70.

Osher RH. Negative dysphotopsia: long-term study and possible explanation for transient symptoms. J Cataract Refract Surg 2008; 34:1699– 1707.

Holladay JT, Simpson MJ. Negative dysphotopsia: causes and rationale for prevention and treatment. J Cataract Refract Surg 2017; 43:263–275.

Masket S, Fram N, Cho A, et al. Surgical management of negative dysphotopsia. J Cataract Refract Surg 2018; 44:6–16.

Folden DV. Neodymium: YAG laser anterior capsulectomy: surgical option in the management of negative dysphotopsia. J Cataract Refract Surg 2013; 39:1110–1115.

Cooke DL, Kasko S, Platt LO. Resolution of negative dysphotopsia after laser anterior capsulotomy. J Cataract Refract Surg 2013; 39:1107–1109.

Johansson B. Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification. Br J Ophthalmol. 2010;94:450–5.

Cullin F, Busch T, Lundström M. Economic considerations related to choice of intraocular lens (IOL) and posterior capsule opacification frequency - A comparison of three different IOLs. Acta Ophthalmol. 2014;92:179–83.

Ursell PG, Dhariwal M, Majirska K, Ender F, Kalson-Ray S, Venerus A, et al. Three-year incidence of Nd:YAG capsulotomy and posterior capsule opacification and its relationship to monofocal acrylic IOL biomaterial: a UK real world evidence study. Eye. 2018;32:1579–89.

Ursell PG, Dhariwal M, O’Boyle D, Khan J, Venerus A. 5 year incidence of YAG capsulotomy and PCO after cataract surgery with single-piece monofocal intraocular lenses: a real-world evidence study of 20,763 eyes. Eye (2019) Eye

Chang DF. Single versus three piece acrylic IOLs. Br J Ophthalmol. 2004;88:727–8.

Mylonas G, Prskavec M, Baradaran-Dilmaghani Ret al. Effect of a single-piece and a three-piece acrylic sharp-edged IOL on posterior capsule opacification. Curr Eye Res. 2013;38:86–90.

Kahraman G, Amon M, Ferdinaro C, Nigl K, Walch M. Intraindividual comparative analysis of capsule opacification after implantation of 2 single-piece hydrophobic acrylic intraocular lenses models: three-year follow-up. J Cataract Refract Surg. 2015;41:990–6.

Nixon DR, Woodcock MG. Pattern of posterior capsule opacification models 2 years postoperatively with 2 single-piece acrylic intraocular lenses. J Cataract Refract Surg. 2010;36:929–34.


Download data is not yet available.


How to Cite
Ansari, E. (2020). Posterior Capsulotomy Rate And Dysphotopsias Following Implantation Of Hoya iSert 250 Monofocal Intraocular Lens: 24 Month Study. European Journal of Medical and Health Sciences, 2(3).